Ibuprofen Dosing for Acute Abnormal Uterine Bleeding in Reproductive-Age Women
For acute abnormal uterine bleeding in reproductive-age women, ibuprofen should be dosed at 600-800 mg orally every 6-8 hours with food for 5-7 days during the bleeding episode, which reduces menstrual blood loss by 20-60%. 1, 2
Mechanism and Efficacy
- NSAIDs like ibuprofen work by inhibiting prostaglandin synthesis, which reduces menstrual blood flow acutely and can decrease bleeding by 20-60% when used during active bleeding episodes 1, 2
- Ibuprofen is specifically recommended as a first-line adjunctive therapy for persistent bleeding despite hormonal treatment 1
- The medication should be taken with food to minimize gastrointestinal side effects 3
Specific Dosing Regimen
- The recommended dose is 600-800 mg orally every 6-8 hours for the first 24 hours post-procedure or during acute bleeding episodes 3
- Treatment duration should be limited to 5-7 days during the bleeding episode 1, 2, 4
- For ongoing management, ibuprofen can be combined with hormonal therapies (combined oral contraceptives or progestins) for enhanced efficacy 1
Critical Contraindications and Precautions
- Aspirin should be avoided as it can paradoxically increase bleeding 2
- NSAIDs should generally be avoided in women with spontaneous coronary artery dissection (SCAD) given their association with myocardial infarction and thrombosis 3
- Tranexamic acid (which reduces bleeding by 40-60%) is more effective than NSAIDs but is contraindicated in patients with active thromboembolic disease or history/risk of thrombosis 1, 2
When Ibuprofen Alone Is Insufficient
- If bleeding persists beyond 5-7 days of NSAID therapy, hormonal treatment should be initiated with combined oral contraceptives containing 30-35 μg ethinyl estradiol as first-line therapy 1, 4
- For hemodynamically unstable patients (saturating a large pad hourly for ≥4 hours), urgent evaluation and consideration of high-dose hormonal therapy or tranexamic acid is required 2
- Pregnancy must be ruled out with β-hCG testing before initiating any treatment in all reproductive-age women 2